Healthequity Financial Statements From 2010 to 2022

HQY
 Stock
  

USD 61.39  2.14  3.37%   

Healthequity financial statements provide useful quarterly and yearly information to potential Healthequity investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Healthequity financial statements helps investors assess Healthequity's valuation, profitability, and current liquidity needs.
We have found one hundred seven available fundamental trends for Healthequity, which can be analyzed and compared to other ratios and to its competitors. Make sure you confirm all of Healthequity regular market performance against the performance between 2010 and 2022 to make sure the company can sustain itself down the road.
Healthequity Average Assets are fairly stable at the moment as compared to the past year. Healthequity reported Average Assets of 3.13 Billion in 2021. Average Equity is likely to rise to about 2 B in 2022, whereas Net Income Per Employee is likely to drop (12.2 K) in 2022.
  
Refresh
Check Healthequity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Healthequity main balance sheet or income statement drivers, such as Direct Expenses of 359.1 M, Cost of Revenue of 359.1 M or Gross Profit of 457.2 M, as well as many exotic indicators such as Interest Coverage of 1.19, Long Term Debt to Equity of 0.71 or PPandE Turnover of 35.09. Healthequity financial statements analysis is a perfect complement when working with Healthequity Valuation or Volatility modules. It can also supplement various Healthequity Technical models. Please check the analysis of Healthequity Correlation against competitors.

Healthequity Revenues

816.28 Million

Share

Healthequity Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.4 B3.1 BB
Increasing
Slightly volatile
Cash and Equivalents214.9 M225.4 M145.4 M
Increasing
Slightly volatile
Investments48.1 M46.9 M41.5 M
Increasing
Slightly volatile
Investments Current48.1 M46.9 M41.5 M
Increasing
Slightly volatile
Property Plant and Equipment Net93.9 M87 M34.5 M
Increasing
Slightly volatile
Inventory647.8 K680.8 K518.5 K
Increasing
Slightly volatile
Tax Assets16.6 K16.2 K2.1 M
Decreasing
Slightly volatile
Trade and Non Trade Receivables94.3 M87.4 M33.4 M
Increasing
Slightly volatile
Trade and Non Trade Payables29.7 M27.5 M6.2 M
Increasing
Slightly volatile
Goodwill and Intangible Assets2.8 B2.6 B778.2 M
Increasing
Slightly volatile
Total Liabilities1.4 B1.3 B433.4 M
Increasing
Slightly volatile
Shareholders EquityB1.9 B589.3 M
Increasing
Slightly volatile
Accumulated Retained Earnings Deficit141.5 M176.1 M72.8 M
Increasing
Slightly volatile
Current Assets316.7 M351.3 M201.8 M
Increasing
Slightly volatile
Assets Non CurrentB2.8 B829.2 M
Increasing
Slightly volatile
Current Liabilities165.3 M153.2 M61.2 M
Increasing
Slightly volatile
Liabilities Non Current1.2 B1.1 B372.2 M
Increasing
Slightly volatile
Tax Liabilities68.9 K69.3 K75.8 K
Decreasing
Slightly volatile
Total DebtBB939.9 M
Increasing
Slightly volatile
Debt Current32.9 M20.9 M38.2 M
Increasing
Slightly volatile
Debt Non Current973.7 M987.3 M1.2 B
Decreasing
Slightly volatile
Shareholders Equity USDB1.9 B589.3 M
Increasing
Slightly volatile
Cash and Equivalents USD214.9 M225.4 M145.4 M
Increasing
Slightly volatile
Total Debt USDBB939.9 M
Increasing
Slightly volatile
Accounts Payable29.7 M27.5 M6.2 M
Increasing
Slightly volatile
Receivables94.3 M87.4 M33.2 M
Increasing
Slightly volatile
Inventories292.4 K193.5 K337.7 K
Decreasing
Stable

Healthequity Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues816.3 M756.6 M303.7 M
Increasing
Slightly volatile
Cost of Revenue359.1 M332.9 M129.1 M
Increasing
Slightly volatile
Selling General and Administrative Expense154.3 M143 M59.8 M
Increasing
Slightly volatile
Research and Development Expense169.8 M157.4 M50.9 M
Increasing
Slightly volatile
Operating Expenses483.3 M447.9 M150.8 M
Increasing
Slightly volatile
Interest Expense39.5 M36.6 M10.6 M
Increasing
Slightly volatile
Income Tax Expense(23 M)(22.5 M)(1.7 M)
Decreasing
Slightly volatile
Consolidated Income(45.5 M)(44.3 M)12.9 M
Decreasing
Stable
Net Income to Non Controlling Interests(1.7 M)(1.7 M)1.3 M
Decreasing
Slightly volatile
Net Income(45.5 M)(44.3 M)12.4 M
Decreasing
Stable
Net Income Common Stock(45.5 M)(44.3 M)12.4 M
Decreasing
Stable
Weighted Average Shares72.9 M83.1 M45.1 M
Increasing
Slightly volatile
Weighted Average Shares Diluted76.5 M83.1 M55.2 M
Increasing
Slightly volatile
Earning Before Interest and Taxes EBIT(31 M)(30.2 M)21.2 M
Increasing
Very volatile
Revenues USD816.3 M756.6 M303.7 M
Increasing
Slightly volatile
Net Income Common Stock USD(45.5 M)(44.3 M)12.4 M
Decreasing
Stable
Earning Before Interest and Taxes USD(31 M)(30.2 M)21.2 M
Increasing
Very volatile
Gross Profit457.2 M423.7 M174.6 M
Increasing
Slightly volatile
Operating Income(24.9 M)(24.2 M)23.9 M
Increasing
Very volatile
Direct Expenses359.1 M332.9 M129.1 M
Increasing
Slightly volatile

Healthequity Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Investment Acquisitions and Disposals2.3 M2.1 M(3.8 M)
Increasing
Very volatile
Net Cash Flow from Financing328.7 M394.9 M184.8 M
Increasing
Slightly volatile
Issuance Repayment of Debt Securities (66.8 M)(65 M)528.8 M
Increasing
Very volatile
Issuance Purchase of Equity Shares503.2 M466.4 M149.5 M
Increasing
Slightly volatile
Net Cash Flow from Investing(656.1 M)(639.2 M)(251.6 M)
Decreasing
Slightly volatile
Net Cash Flow from Operations117 M141 M67.7 M
Increasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents(106.1 M)(103.4 M)8.9 M
Decreasing
Stable
Share Based Compensation56.9 M52.8 M18.8 M
Increasing
Slightly volatile
Depreciation Amortization and Accretion148 M137.2 M41 M
Increasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(0.54)(0.53)0.3021
Decreasing
Stable
Earnings per Diluted Share(0.54)(0.53)0.1529
Decreasing
Very volatile
Earnings per Basic Share USD(0.54)(0.53)0.3021
Decreasing
Stable
Return on Average Equity(0.0246)(0.024)0.2819
Decreasing
Slightly volatile
Return on Average Assets(0.0144)(0.014)0.0022
Increasing
Slightly volatile
Return on Invested Capital(0.0267)(0.026)0.1514
Increasing
Stable
Gross Margin0.630.560.569
Increasing
Slightly volatile
Profit Margin(0.0605)(0.059)0.1121
Decreasing
Slightly volatile
EBITDA Margin0.210.1410.2258
Increasing
Very volatile
Return on Sales(0.0411)(0.04)0.1245
Decreasing
Slightly volatile
Asset Turnover0.250.2420.7235
Decreasing
Slightly volatile
Enterprise Value over EBITDA48.845.12443.8278
Increasing
Stable
Enterprise Value over EBIT(164)(160)34.5223
Decreasing
Slightly volatile
Price to Earnings Ratio(103)(101)89.4843
Increasing
Very volatile
Sales per Share8.489.1017.0004
Decreasing
Very volatile
Price to Sales Ratio7.395.8729.1119
Increasing
Very volatile
Price to Book Value2.472.4126.705
Decreasing
Slightly volatile
Debt to Equity Ratio0.730.677(0.2162)
Increasing
Slightly volatile
Current Ratio2.352.2946.3212
Increasing
Very volatile
Free Cash Flow per Share0.910.8351.2243
Decreasing
Slightly volatile
Book Value per Share24.0422.2847.7122
Increasing
Slightly volatile
Tangible Assets Book Value per Share6.035.8724.908
Increasing
Slightly volatile
Total Assets Per Share40.0137.086415.967
Increasing
Slightly volatile
Cash Flow Per Share1.511.68291.6001
Decreasing
Stable
Return on Investment(0.96)(0.9415)17.2051
Decreasing
Slightly volatile
Operating Margin(3.29)(3.2037)14.6959
Decreasing
Slightly volatile
Calculated Tax Rate(134)(130)(30.0957)
Decreasing
Slightly volatile
Receivables Turnover11.59.445411.5885
Decreasing
Slightly volatile
Inventory Turnover228211155
Increasing
Slightly volatile
PPandE Turnover35.0928.833335.6719
Decreasing
Slightly volatile
Cash and Equivalents Turnover2.692.73023.145
Decreasing
Slightly volatile
Accounts Payable Turnover67.0951.898979.3967
Increasing
Slightly volatile
Accrued Expenses Turnover10.146.542511.3992
Decreasing
Slightly volatile
Interest Coverage1.191.1627.9131
Decreasing
Slightly volatile
Long Term Debt to Equity0.710.49771.0266
Decreasing
Slightly volatile
Quick Ratio2.041.99235.4482
Increasing
Very volatile
Net Current Assets as percentage of Total Assets6.556.377333.5729
Decreasing
Stable
Revenue to Assets0.250.24350.6182
Decreasing
Slightly volatile

Healthequity Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax(68.5 M)(66.7 M)10.8 M
Decreasing
Stable
Earnings Before Interest Taxes and Depreciation Amortization EBITDA95.1 M107 M60.5 M
Increasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD95.1 M107 M60.5 M
Increasing
Slightly volatile
Market Capitalization4.4 B4.5 B2.8 B
Increasing
Slightly volatile
Enterprise Value4.7 B4.8 B2.9 B
Increasing
Slightly volatile
Invested Capital1.2 B1.1 B393.4 M
Increasing
Slightly volatile
Average EquityB1.9 B559.4 M
Increasing
Slightly volatile
Average Assets3.4 B3.1 B956.3 M
Increasing
Slightly volatile
Invested Capital Average1.2 B1.1 B362.2 M
Increasing
Slightly volatile
Tangible Asset Value418.3 M488.1 M249.3 M
Increasing
Slightly volatile
Free Cash Flow65.6 M69.4 M45.1 M
Increasing
Slightly volatile
Working Capital200.6 M198.2 M144.4 M
Increasing
Slightly volatile
Revenue Per Employee194.2 K203.6 K195.5 K
Increasing
Slightly volatile
Net Income Per Employee(12.2 K)(11.9 K)15 K
Decreasing
Very volatile

Healthequity Fundamental Market Drivers

Short Percent Of Float5.64%
Forward Price Earnings40.95
Shares Short Prior Month4.3M
Average Daily Volume Last 10 Day1.18M
Average Daily Volume In Three Month772.04k
Date Short Interest29th of April 2022
Fifty Day Average63.48
Two Hundred Day Average59.07

Healthequity Upcoming Events

Upcoming Quarterly Report21st of March 2022
Next Financial Report6th of June 2022
Next Fiscal Quarter End31st of January 2022
Next Fiscal Year End21st of March 2022
Last Quarter Report31st of October 2021
Last Financial Announcement31st of January 2021

About Healthequity Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Healthequity income statement, its balance sheet, and the statement of cash flows. Healthequity investors use historical funamental indicators, such as Healthequity's revenue or net income, to determine how well the company is positioned to perform in the future. Although Healthequity investors may use each financial statement separately, they are all related. The changes in Healthequity's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Healthequity's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Healthequity Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Healthequity. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Cost of Revenue332.9 M359.1 M
Revenues756.6 M816.3 M
Revenue to Assets 0.24  0.25 
Revenue Per Employee203.6 K194.2 K
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.

Healthequity Investors Sentiment

The influence of Healthequity's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Healthequity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Healthequity Implied Volatility

    
  37.63  
Healthequity's implied volatility exposes the market's sentiment of Healthequity stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Healthequity's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Healthequity stock will not fluctuate a lot when Healthequity's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Healthequity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Healthequity's short interest history, or implied volatility extrapolated from Healthequity options trading.

Current Sentiment - HQY

Healthequity Investor Sentiment

Greater number of Macroaxis users are currently bullish on Healthequity. What is your judgment towards investing in Healthequity? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Healthequity using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please check the analysis of Healthequity Correlation against competitors. Note that the Healthequity information on this page should be used as a complementary analysis to other Healthequity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Transformation module to use Price Transformation models to analyze depth of different equity instruments across global markets.

Complementary Tools for Healthequity Stock analysis

When running Healthequity price analysis, check to measure Healthequity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healthequity is operating at the current time. Most of Healthequity's value examination focuses on studying past and present price action to predict the probability of Healthequity's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Healthequity's price. Additionally, you may evaluate how the addition of Healthequity to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Is Healthequity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Healthequity. If investors know Healthequity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Healthequity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.96
Market Capitalization
5.5 B
Quarterly Revenue Growth YOY
0.12
Return On Assets
0.0059
Return On Equity
-0.0299
The market value of Healthequity is measured differently than its book value, which is the value of Healthequity that is recorded on the company's balance sheet. Investors also form their own opinion of Healthequity's value that differs from its market value or its book value, called intrinsic value, which is Healthequity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Healthequity's market value can be influenced by many factors that don't directly affect Healthequity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Healthequity's value and its price as these two are different measures arrived at by different means. Investors typically determine Healthequity value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Healthequity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.